Refactor Capital
www.refactor.comRefactor invests in seed-stage hard tech companies primarily in the US, typically leading or co-leading pre-seed and seed rounds with $1-2M checks. They target 10% ownership and focus on domains including aerospace, biotech, critical materials, earth systems, energy, and health.
Is Refactor Capital right for your startup?
Upload your pitch deck and get an AI-powered match score in minutes. See exactly how well you fit their investment criteria.
See If You're a MatchInvestment Thesis
Refactor invests in seed-stage hard tech founders who aim to commercialize real science and scale real systems. The firm believes that ‘the most enduring companies are created by founders willing to commercialize real science and scale real systems.’ They focus on companies solving ‘hard but not impossible problems’ at the intersection of computation and physical sciences, with the goal of refactoring—improving efficiency and scalability—within their respective industries.
What Sets Them Apart
- Solo capitalist structure - Zal Bilimoria is the only employee, enabling fast decision-making and direct founder access
- Personal, hands-on approach: 'I will make your vision and journey my primary focus. Expect highly responsive, one-on-one attention from me'
- Deep technical expertise from Zal's background at a16z leading early bio and health investments and helping launch a16z's first Bio Fund
- Comprehensive founder support beyond capital including CFO support, communications training, and mental fitness programs
- Consistent track record across fund cycles - 4 funds with $225M in AUM, expanding into new hard tech domains nearly every year
Portfolio Highlights
General Galactic
Aerospace
Astranis
Aerospace
Octant
Biotech
Miist
Biotech
Parallel Bio
Biotech
BBB
Biotech
Biorender
Biotech
Epana
Biotech
+ 51 more companies in their portfolio
Ready to find your perfect investor match?
Get Started Free